Carlos Marcelo Telleria

University Of South Dakota

$1,149,435

Attributed

$1,149,435

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $425.6K · FY2005–12

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

Funding mix

By agency

NIH$1,149,435 · 8

By mechanism

K22$524,712 · 1

R15$425,596 · 1

P20$199,127 · 6

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsMalignant Neoplasm Of OvaryDesignMifepristoneFeasibility StudiesCancer CellSteroidsPharmaceutical PreparationsResearch PersonnelGrowthGrowth InhibitorsResearch StudyRu-486CellsIn VitroIn VivoCell DeathWomanMolecularBaseGene ExpressionCause Of DeathDiagnosisCyclin-Dependent Kinase Inhibitor